Sr. Manager, International Order-to-Cash Process Control Advisor

Senior Manager, International Order-to-Cash Process Control Advisor

The Business Controls Function (BCF) is a key contributor to the Company's overall enterprise risk management strategy. The BCF is a global organization with resources based around the world. The BCF Leadership Team and many BCF team members are based in Princeton, NJ. The BCF is a "second line" risk management function (in accordance with the Institute of Internal Auditors' "three lines" concept), reporting directly to the Corporate Controller, and partnering with Finance, business operations, functional leads and senior management throughout the Company.

The Senior Manager, International Order-to-Cash (OTC) Process Control Advisor (PCA) within BCF will play a pivotal role in supporting the Senior Director, Business Controls Function. This role will be providing essential guidance to the centralized process-focused BCF team members regarding international order-to-cash internal controls (including Internal Controls over Financial Reporting or "ICFR"), as well as corporate policies and directives.

The Senior Manager will represent BCF as a leader and international OTC subject matter expert in controls and business process optimization. The Senior Manager will actively participate in various activities including:

• Responsible for control assessments of the international OTC controls within the BCF's controls program. This includes responsibility for the OTC controls within commercial markets around the world, other than the United States.
• Drive coordination with Business Process Owners of international OTC activities to mitigate risk.
• Collaborate on best practices and partner with the business process owners.
• Remain abreast of developments and changing risk environment.
• Incorporate new areas of risk into the Company's controls program for OTC controls outside the US.
• Identify improvement opportunities with the core business functions and driving enhancements of the BCF's overall financial control program.
• Serve as the controls subject matter expert on the end-to-end process for the OTC cycle for markets outside the United States.

Key Responsibilities and Major Duties

• Contribute to the collaborative and results-driven team environment.
• Contribute to the development and execution of the company's strategic plans by providing risk and controls insights and analysis for international OTC controls.
• Evaluate potential business opportunities, mergers/acquisitions, partnerships, and/or other company initiatives from a risk and controls standpoint for international OTC controls.
• Support professional development and training initiatives for the BCF team members.
• Deliver training and presentations to the BCF network and applicable business process personnel regarding internal controls.

• Lead the annual risk assessment for the international OTC process, for commercial markets outside the United States, designed to address financial, operational, and fraud risks, to drive prioritization of PCA project work throughout the year.
• Facilitate annual walk-throughs of international internal controls for OTC cycle for the BCF's management and the Company's external auditors. This will include facilitating walkthroughs for in the in-scope SOX markets for OTC other than the US.
• Update process flows and related narratives, as necessary.
• Identify design gaps in international OTC internal controls and work with process owners to implement or change internal controls.
• Review Sarbanes-Oxley testing results and assess the quality of testing and related test conclusions.
• Review and comment upon service auditor reports annually, including benchmarking against Client internal controls for any risk areas disclaimed in the report.
• On a quarterly basis and more frequently as required, work with business partners to understand and evaluate changes in our international OTC control environment for SOX reporting and compliance purposes.
• On a quarterly basis, evaluate out of period adjustments to the financial statements, control failures and Global Internal Audit & Assurance (GIA) observations for potential Sarbanes-Oxley (SOX) deficiency…